Johnson & Johnson (JNJ)

Overview Products Trials

Market Cap	$353.05B
Revenue TTM
Earnings Date	2025-01-22
Website	https://www.jnj.com

Upcoming PDUFA Dates

No upcoming PDUFAs found

Upcoming Trial Readouts

Feature coming soon

Upcoming Patent Expirations

Brand Name	Patent Number	Expire Date
XARELTO	9415053*PED	5/13/2025
INVOKANA	8222219*PED	10/11/2025
INVOKAMET	8222219*PED	10/11/2025
INVOKAMET XR	8222219*PED	10/11/2025
SPRAVATO	9592207	3/20/2027
INVOKANA	7943788	7/14/2027
INVOKAMET	7943788	7/14/2027
INVOKAMET XR	7943788	7/14/2027
INVOKANA	8513202	12/3/2027
INVOKAMET	8513202	12/3/2027
INVOKAMET XR	8513202	12/3/2027
INVOKANA	7943788*PED	1/14/2028
INVOKAMET	7943788*PED	1/14/2028
INVOKAMET XR	7943788*PED	1/14/2028
INVOKANA	8513202*PED	6/3/2028
INVOKAMET	8513202*PED	6/3/2028
INVOKAMET XR	8513202*PED	6/3/2028
INVOKANA	7943582	2/26/2029
INVOKAMET	7943582	2/26/2029
INVOKAMET XR	7943582	2/26/2029
INVOKANA	7943582*PED	8/26/2029
INVOKAMET	7943582*PED	8/26/2029
INVOKAMET XR	7943582*PED	8/26/2029
INVOKAMET	11576894	7/6/2030
INVEGA SUSTENNA	9439906	1/26/2031
INVOKANA	10617668	5/11/2031
INVOKANA	10617668*PED	11/11/2031
Stelara	8,852,889	7/6/2032
Stelara	9,475,858	7/6/2032
Stelara	8,852,889	7/6/2032
Stelara	9,475,858	7/6/2032
SPRAVATO	8785500	3/5/2033
Stelara	9,217,168	3/14/2033
Stelara	9,663,810	3/14/2033
Stelara	9,217,168	3/14/2033
Stelara	9,663,810	3/14/2033
XARELTO	9539218	2/17/2034
SPRAVATO	11446260	3/14/2034
XARELTO	9539218*PED	8/17/2034
SPRAVATO	10869844	9/10/2035
SPRAVATO	11173134	9/10/2035
SPRAVATO	11311500	9/10/2035
INVEGA HAFYERA	10143693	4/5/2036
INVEGA TRINZA	10143693	4/5/2036
XARELTO	10828310	1/31/2039
XARELTO	10828310*PED	7/31/2039
Stelara	10,961,307	9/24/2039
Stelara	10,961,307	9/24/2039
SPRAVATO	11883526	2/18/2040
INVEGA HAFYERA	11304951	5/7/2041
INVEGA HAFYERA	11324751	5/7/2041
INVEGA TRINZA	11304951	5/7/2041
INVEGA TRINZA	11324751	5/7/2041
INVEGA HAFYERA	11666697	11/24/2041
INVEGA TRINZA	11666697	11/24/2041